AI Analysis AI Analysis of VCYT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add VCYT to Watchlist?
Some Reasons Why To Add VCYT:
  • +95.9% price growth over the last year
  • Excellent financial health (Piotroski 7/9)
  • High gross margin of 72.2%
PDF

High volatility in Veracyte stock price on Friday which ended trading at $46.32
(Updated on Jul 31, 2026)

Sell candidate since Jul 31, 2026

The Veracyte stock price fell by -22.52% on the last day (Friday, 31st Jul 2026) from $59.78 to $46.32. During the last trading day the stock fluctuated 15.12% from a day low at $43.52 to a day high of $50.10. The price has fallen in 6 of the last 10 days and is down by -21.66% for this period. Volume has increased on the last day by 5 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 6 million shares were bought and sold for approximately $277.54 million.

Given the current short-term trend, the stock is expected to rise 48.14% during the next 3 months and, with a 90% probability hold a price between $68.62 and $102.75 at the end of this 3-month period.

VCYT Signals & Forecast

There are few to no technical positive signals at the moment. The Veracyte stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $55.37 and $55.98. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, June 26, 2026, and so far it has fallen -23.43%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Veracyte stock

Veracyte finds support from accumulated volume at $45.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $6.58 (15.12%) between high and low. For the last week, the stock has had daily average volatility of 7.53%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VCYT) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Veracyte to open at $46.65, and during the day (based on 14 day Average True Range), to move between $44.45 and $48.19, which gives a possible trading interval of +/-$3.75 (+/-8.44%) up or down from last closing price. If Veracyte takes out the full calculated possible swing range there will be an estimated 8.44% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $45.19 (2.44%) than the resistance at $49.94 (7.82%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Veracyte stock A Buy?

The Veracyte stock holds several negative signals and despite the positive trend, we believe Veracyte will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Sell candidate.

Current score: -2.651 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $46.65 ( 0.705%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

VCYT Performance

Trading levels for VCYT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 53.23 14.91%
R2 50.71 9.48%
R1 49.16 6.13%
Price 46.32
S1 44.13 -4.72%
S2 42.58 -8.07%
S3 40.07 -13.50%

Accumulated Volume Support & Resistance Levels

Level Price
R3 53.63 15.78%
R2 50.92 9.93%
R1 49.94 7.82%
Price 46.32
S1 45.19 -2.44%
S2 41.19 -11.08%
S3 40.76 -12.00%

FAQ

What is the symbol for Veracyte Stock and on which exchange is it traded?
The symbol for Veracyte is VCYT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Veracyte Stock?
The Veracyte stock holds several negative signals and despite the positive trend, we believe Veracyte will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Sell candidate.

How to buy Veracyte Stock?
Veracyte Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Veracyte Stock.

What's the current price of Veracyte Stock?
As of the end of day on the Jul 31, 2026, the price of an Veracyte (VCYT) share was $46.32.

What is the 52-week high and low for Veracyte Stock?
The 52-week high for Veracyte Stock is $60.91 and the 52-week low is $22.97.

What is the market capitalization of Veracyte Stock?
As of the Jul 31, 2026, the market capitalization of Veracyte is 3.696B.

When is the next earnings date for Veracyte?
The upcoming earnings date for Veracyte is Nov 03, 2026.
Click to get the best stock tips daily for free!
ABOUT VERACYTE
Veracyte
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
3.01% Jul 27
UNFI
$49.05
1.39% Jul 27
BIIB
$202.19
2.84% Jul 24
S
SW
$43.71
8.72% Jul 23
I
INTR
$5.62
0.356% Jul 20

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE